AbbVie Sets Out To Win Over Investors In Its First Financial Call
This article was originally published in The Pink Sheet Daily
Executive Summary
Management highlighted the ongoing growth potential of Humira and a late-stage pipeline that it says has the ability to generate between $4 billion and $6 billion of growth during the new pharmaceutical company’s first financial call with investors.